Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer.
about
Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast Cancer.Genomic mutation-driven metastatic breast cancer therapy: a single center experienceDifferentially expressed miRNAs in triple negative breast cancer between African-American and non-Hispanic white women.A novel guaiane sesquiterpene derivative, guai-2-en-10α-ol, from Ulva fasciata Delile inhibits EGFR/PI3K/Akt signaling and induces cytotoxicity in triple-negative breast cancer cells.Exploring phenotype patterns of breast cancer within somatic mutations: a modicum in the intrinsic code.Divergent JNK Phosphorylation of HDAC3 in Triple-Negative Breast Cancer Cells Determines HDAC Inhibitor Binding and Selectivity.miR-10b, miR-26a, miR-146a And miR-153 Expression in Triple Negative Vs Non Triple Negative Breast Cancer: Potential Biomarkers.PIK3CA mutation, reduced AKT serine 473 phosphorylation, and increased ERα serine 167 phosphorylation are positive prognostic indicators in postmenopausal estrogen receptor-positive early breast cancer.Endogenous Akt Activity Promotes Virus Entry and Predicts Efficacy of Novel Chimeric Orthopoxvirus in Triple-Negative Breast Cancer.Precision medicine based on tumorigenic signaling pathways for triple-negative breast cancerNew Insights into the Role of Exercise in Inhibiting mTOR Signaling in Triple-Negative Breast CancerDetection of PIK3/AKT pathway in Moroccan population with triple negative breast cancer
P2860
Q30275521-E23AD579-FEEF-41E8-B9D6-03431D716581Q33688687-C26CD2CC-9D65-458E-AAC6-2FB9BBF328E2Q37694781-A07EC56A-A0E1-43B7-A9CE-19B09A33E61BQ38695912-3A4B8744-2E4F-42D8-A7C6-FE96FA0E4EEEQ39752527-81C92B66-0399-48BE-ACFE-38F15B643E92Q46181428-7B101C12-1773-43AD-A16D-8734B52A4043Q51182190-B3B15855-1378-4561-AC24-4F8B9B466DA4Q55001013-F106D4E8-B799-4441-BEEC-D1592DD557FFQ55466158-46BD4687-F5A5-45EC-ABEC-D39CCED8AC22Q57105411-F8518B14-72F5-4BCD-AD23-74D7E7FEA564Q58200565-CEFA9331-1F57-43B2-ACBC-D465002D2E68Q58725505-30A982A9-1085-4481-BE1E-A00C48E741E0
P2860
Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer.
@ast
Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer.
@en
type
label
Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer.
@ast
Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer.
@en
prefLabel
Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer.
@ast
Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer.
@en
P2093
P2860
P50
P1433
P1476
Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer
@en
P2093
Alessandra Manca
Francesca Sanges
Giovanna Pira
Giovanni Sotgiu
Luciano Murgia
Maria Gabriela Uras
Maria Giuseppina Sarobba
Maria Rosaria De Miglio
Maria Rosaria Muroni
Sandra Orrù
P2860
P304
P356
10.1371/JOURNAL.PONE.0141763
P407
P577
2015-11-05T00:00:00Z